Page last updated: 2024-08-05 12:17:35
(18)F radiopharmaceutical
null
ChEBI ID: 49127
Members (4)
Member | Definition | Role |
---|---|---|
bay94 9172 | A member of the class of stilbenoids in which the para-hydrogens of stilbene are replaced by methylamino and 2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy) groups. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | florbetaben ((18)F) |
florbetapir f 18 | An aromatic ether consisting of a pyridine ring substituted at position 2 by a 2-{2-[2-((18)F)fluoroethoxy]ethoxy}ethoxy group and at position 5 and a 2-(4-methylaminophenyl)vinyl group. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | florbetapir F-18 |
fluorodopa f 18 | 6-((18)F)fluoro-L-dopa | |
vizamyl | A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by 3-((18)F)fluoro-4-(methylamino)phenyl and hydroxy groups at positions 3 and 6 respectively. A positron emission tomography imaging ligand for the detection of amyloid aggregation associated with Alzheimer disease. | flutemetamol ((18)F) |
Research
Studies (1,126)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 22 (1.95) | 18.7374 |
1990's | 191 (16.96) | 18.2507 |
2000's | 226 (20.07) | 29.6817 |
2010's | 559 (49.64) | 24.3611 |
2020's | 128 (11.37) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 73 (6.17%) | 5.53% |
Reviews | 104 (8.79%) | 6.00% |
Case Studies | 136 (11.50%) | 4.05% |
Observational | 7 (0.59%) | 0.25% |
Other | 863 (72.95%) | 84.16% |